Allogeneic CD19-targeting CAR-γδT cell therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Allogeneic CD19-targeting CAR-γδT cell therapy, covering 2025-08-06 to 2025-08-06. Get the full timeline:
Most recent: Clinical Trial Update: Allogenic CD19-targeting CAR-γδT Cell Therapy in R/R NHL [Phase 1, Phase 2]